Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment, By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Swimmer’s Shoulder), By Region, And Segment Forecasts, 2021 - 2028

Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment, By Condition (Tennis Elbow, Golfer’s Elbow, Pitcher’s Elbow, Jumper’s Knee, Swimmer’s Shoulder), By Region, And Segment Forecasts, 2021 - 2028

Tendonitis Treatment Market Growth & Trends

The global tendonitis treatment market size is expected to reach USD 235.4 billion by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.8% from 2021 to 2028. Individuals are proactively participating in sporting or physical activities and the probability of sports-related injuries occurring is rising, thereby contributing to the market development and growth. The growing global geriatric population is susceptible to tendonitis or could be suffering from bone disorders, osteoporosis, rheumatoid arthritis, diabetes, and osteoarthritis. Constant innovation of technologies and therapies in treating tendonitis is contributing to the growth. Supportive government initiatives and significant investments and collaborations amongst key players to expand product offerings are boosting the market growth.

Over the past years, the growing reliance on technologies in mapping various factors concerning sports, such as performance assessment, training modules, and sports injuries tracking and monitoring. The shift from proactive to preventive therapies is proving to be beneficial in improving the health status of sports players to prevent injuries. Sporting and physical activities are witnessing significant participation, and this paves way for possibilities of incurring sports injuries. As per Standard Children’s Health, in 2018, out of 30.0 million children and adolescents participating in sports in the U.S., approximately 3.5 million incur some form of sports injury. Furthermore, nearly 775,000 children and adolescents are treated for sports-related injuries in the U.S. every year. Thus, increased participation in sporting activities coupled with the growing adoption of treatment facilities is expected to boost market growth over the forthcoming years.

The key players are increasingly investing in the development of new innovative products to upgrade their product portfolios. The companies are developing products to cater to the growing incidences of sports injury in both competitive and recreational sports players. Market leaders are implementing strategic decisions to gain a competitive edge in the market. Key players are focusing on strengthening their business position in both developed and emerging economies, focusing on product innovation, and supplement organic growth through acquisitions. For instance, in March 2019, Stryker acquired OrthoSpace Ltd. to expand its existing sporting medicine and therapy segment.

The emergence of the Covid-19 pandemic has altered the methods of care delivery in treating tendonitis. Due to the temporary lockdowns, travel restrictions, and high infection load in the healthcare facilities, the market has been negatively impacted. The shortage of skilled healthcare personnel treating tendonitis has restrained the development and growth of the pandemic. Cancellation or postponement of sports injuries implies a decline of sports injuries, which eventually negatively influences the business revenue earnings. The decline in non-pharmacological therapies and surgeries is hindering the market growth.

Tendonitis Treatment Market Report Highlights

  • The market is expected to grow well over the forecast period owing to the increasing prevalence of tendonitis and the introduction of new and innovative therapies
  • The therapy segment dominated the market in 2020 due to the rising occurrence of sports injuries and rising awareness levels towards non-pharmacological therapies and easy availability
  • The Achilles tendonitis segment dominated the market in 2020 due to the high occurrence of the medical condition in both competitive and recreational sports players
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 List of Secondary Sources
1.5 List of Primary Sources
1.6 Information or Data Analysis
1.6.1 Data Analysis Models
1.7 Market Formulation & Validation
1.7.1 Approach 1: Commodity Flow Approach
1.7.2 Global Market: CAGR Calculation
1.8 Abbreviations
1.9 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Tendonitis Treatment Market Estimates and Forecasts, 2016 - 2028 (USD Million)
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Tendonitis Market Summary, 2020
Chapter 3 Tendonitis Treatment Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.2 Ancillary market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 Product Pipeline Analysis
3.5 Industry Analysis
3.5.1 Consumer behavior analysis
3.5.2 Market influencer analysis
3.5.2.1 North America
3.5.2.2 Europe
3.5.2.3 Asia Pacific
3.5.2.4 Latin America
3.5.2.5 MEA
3.5.3 List of key end-users, by product
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards & compliance
3.6.2.1 CPT Coding implications
3.6.2.2 HCPCS Coding implications
3.6.3 Safety
3.7 Tendonitis Treatment Market Dynamics
3.7.1 Market driver analysis
3.7.1.1 Increasing prevalence of sports injuries
3.7.1.2 Technological advancements pertaining to novel product development
3.7.1.3 Growing awareness of tendonitis treatment options
3.7.2 Market restraint analysis
3.7.2.1 Insurance coverage is limited in emerging countries
3.8 Tendonitis Treatment Market Analysis Tools
3.8.1 Industry Analysis - Porters
3.8.1.1 Supplier Power- Moderately High
3.8.1.2 Buyer Power- Moderate
3.8.1.3 Threat Of Substitutes- Moderate
3.8.1.4 Threat Of New Entrants- Low
3.8.1.5 Competitive Rivalry- High
3.8.2 PESTEL Analysis
3.8.2.1 Political Landscape
3.8.2.2 Economic Landscape
3.8.2.3 Social Landscape
3.8.2.4 Technology Landscape
3.8.2.5 Environmental Landscape
3.8.2.6 Legal landscape
3.8.3 Major Deals & Strategic Alliances Analysis
Chapter 4 Tendonitis Treatment Market: Competitive Analysis
4.1 Market Participation Categorization
4.1.1 Regional network map
4.1.2 Innovators
4.1.3 Key company market share analysis, 2020
4.1.4 Company market share by region, 2020
4.2 Public Companies
4.2.1 Company market position analysis
4.2.2 Heat Map Analysis
4.3 Private Companies
4.3.1 List of emerging companies in VAD Market Space
4.3.2 Heat Map analysis
4.4 Vendor Landscape
4.4.1 List of key distributors and channel partners
4.4.2 Key customers
4.4.3 Funding Outlook
Chapter 5 Tendonitis Treatment Market: Treatment Estimates & Trend Analysis
5.1 Treatment Market Share Analysis, 2020 & 2028
5.2 Treatment Dashboard
5.2.1 Therapy
5.2.1.1 Therapy Market Estimates And Forecasts, 2016 - 2028 (USD Million)
5.2.1.1.1 Hot and Cold Therapy
5.2.1.1.2 Physical Therapy
5.2.1.1.3 Shockwave Therapy
5.2.2 Surgery
5.2.2.1 Surgery Market Estimates And Forecasts, 2016 - 2028 (USD Million)
Chapter 6 Tendonitis Treatment Market: Condition Estimates & Trend Analysis
6.1 Condition Market Share Analysis, 2020 & 2028
6.2 Condition Dashboard
6.2.1 Tennis Elbow
6.2.1.1 Tennis Elbow market estimates and forecasts, 2016 - 2028 (USD Million)
6.2.2 Golfer's Elbow
6.2.2.1 Golfer's Elbow market estimates and forecasts, 2016 - 2028 (USD Million)
6.2.3 Pitcher's Elbow
6.2.3.1 Pitcher's Elbow market estimates and forecasts, 2016 - 2028 (USD Million)
6.2.4 Jumper's Knee
6.2.4.1 Jumper's Knee market estimates and forecasts, 2016 - 2028 (USD Million)
6.2.5 Swimmer's Shoulder
6.2.5.1 Swimmer's Shoulder market estimates and forecasts, 2016 - 2028 (USD Million)
6.2.6 Achilles Tendonitis
6.2.6.1 Achilles Tendonitis market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 7 Tendonitis Treatment Market: Regional Estimates & Trend Analysis, By Treatment, By Condition
7.1 Regional Dashboard
7.2 Regional Market Snapshot
7.3 Global tendonitis treatment market: Regional Movement Analysis
7.4 Market Share Analysis by Country, 2020
7.4.1 North America
7.4.2 Europe
7.4.3 Asia Pacific
7.4.4 Latin America
7.4.5 MEA
7.5 North America
7.5.1 North America Tendonitis Treatment Market estimates and forecasts, 2016 - 2028 (USD Million)
7.5.2 U.S.
7.5.2.1 U.S. Tendonitis Treatment Market estimates and forecasts, 2016 - 2028 (USD Million)
7.5.3 Canada
7.5.3.1 Canada Tendonitis Treatment Market estimates and forecasts, 2016 - 2028(USD Million)
7.6 Europe
7.6.1 Europe Tendonitis Treatment Market estimates and forecasts, 2016 - 2028 (USD Million)
7.6.2 U.K.
7.6.2.1 U.K. Tendonitis Treatment market estimates and forecasts, 2016 - 2028(USD Million)
7.6.3 Germany
7.6.3.1 Germany Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.6.4 France
7.6.4.1 France Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.6.5 Italy
7.6.5.1 Italy Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.6.6 Spain
7.6.6.1 Spain Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.6.7 Russia
7.6.7.1 Russia Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.7 Asia Pacific
7.7.1 Asia Pacific Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.7.2 Japan
7.7.2.1 Japan Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.7.3 China
7.7.3.1 China Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.7.4 India
7.7.4.1 India Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.7.5 South Korea
7.7.5.1 South Korea Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.7.6 Singapore
7.7.6.1 Singapore Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.7.7 Australia
7.7.7.1 Australia Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.8 Latin America
7.8.1 Latin America Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.8.2 Mexico
7.8.2.1 Mexico Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.8.3 Brazil
7.8.3.1 Brazil Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.8.4 Argentina
7.8.4.1 Argentina Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.9 MEA
7.9.1 MEA Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.9.2 South Africa
7.9.2.1 South Africa Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.9.3 Saudi Arabia
7.9.3.1 Saudi Arabia Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
7.9.4 UAE
7.9.4.1 UAE Tendonitis Treatment market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 8 Company Profiles
8.1 Merck & Co., Inc.
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 AstraZeneca
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 Boehringer Ingelheim Pharmaceuticals, Inc
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Abbott
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Pfizer
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 Bayer AG
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 GlaxoSmithKline, PLC
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Almatica Pharma, Inc.
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 Teva Pharmaceuticals Industries
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook